MHRA bans valproate prescribing for women not in pregnancy prevention programme
MHRA bans valproate prescribing for women not in pregnancy prevention programme
复制标题
MHRA 禁止为未参加怀孕预防计划的女性开丙戊酸处方
DOI：
10.1136/bmj.k1823
复制
发表时间：
2018
影响因子：
--
通讯作者：
Gareth Iacobucci
中科院分区：
文献类型：
--
作者：
Gareth Iacobucci
英国药品和保健品管理局（MHRA）已禁止所有未参加妊娠预防计划的育龄妇女使用抗癫痫药物丙戊酸钠。
该监管机构表示，它已经做出了保护公共健康的决定，并与专业机构，NHS组织以及患者和运动团体密切合作。
已经服用丙戊酸盐的妇女或女孩应该咨询他们的家庭医生，以获得他们的...
The Medicines and Healthcare Products Regulatory Agency (MHRA) has banned the antiepileptic drug sodium valproate in the UK in all women of childbearing potential who are not enrolled in a pregnancy prevention programme.
The regulator said that it had made the decision to protect public health and in close collaboration with professional bodies, NHS organisations, and patient and campaign groups.1
Women or girls who are already taking valproate should consult their GP to have their …